BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 20055848)

  • 1. Subacute cutaneous lupus erythematosus presenting as poikiloderma.
    Hughes R; Loftus B; Kirby B
    Clin Exp Dermatol; 2009 Dec; 34(8):e859-61. PubMed ID: 20055848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute cutaneous lupus erythematosus presenting with generalized poikiloderma.
    Pramatarov K; Vassileva S; Miteva L
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):286-8. PubMed ID: 10642688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poikilodermatous subacute cutaneous lupus erythematosus.
    Marzano AV; Facchetti M; Alessi E
    Dermatology; 2003; 207(3):285-90. PubMed ID: 14571071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course and prognosis of cutaneous lupus erythematosus.
    Tebbe B
    Clin Dermatol; 2004; 22(2):121-4. PubMed ID: 15234012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
    Cohen MR; Crosby D
    J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous paraneoplastic syndrome as an immunologic phenomenon exemplified by paraneoplastic subacute cutaneous lupus erythematosus].
    Trüeb RF; Trüeb RM
    Praxis (Bern 1994); 1999 Oct; 88(44):1803-10. PubMed ID: 10584550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.
    Sontheimer RD
    Autoimmun Rev; 2005 Jun; 4(5):253-63. PubMed ID: 15990071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Bonsmann G; Schiller M; Luger TA; Ständer S
    J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy].
    Ruzicka T; Bieber T; Meurer M
    Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subacute cutaneous lupus erythematosus based on a study of 15 cases].
    Marschalkó M; Dobozy E; Daróczy J; Gyimesi E; Horváth A
    Orv Hetil; 1989 Dec; 130(49):2623-8. PubMed ID: 2689950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E; Wolska H; Blaszczyk M; Jablonska S
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
    Popovic K; Nyberg F; Wahren-Herlenius M; Nyberg F
    Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of lupus erythematosus based upon Japanese patients.
    Tsuchida T
    Autoimmun Rev; 2009 May; 8(6):453-5. PubMed ID: 19162249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.